Observation of Lower Urinary Tract Symptoms and Other Signs of Benign Prostatic Hyperplasia in Patients with Tuberculosis

Clicks: 229
ID: 275790
2022
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #13 of 57 articles by views in International Journal of Health Systems and Medical Sciences

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
In the world, in recent years, special attention has been paid to the negative impact of urological diseases on public health. Determining the true prevalence of urological diseases requires an assessment of the so-called. occult urological disease. Targeted screening of the population is more informative than analysis of health care visit data to address this issue. The reason for this is that treatment depends on many factors, such as the development of infrastructure and medical care, its availability, general and medical culture, habits, customs and mentality of the population, which affect their medical activity.
Reference Key
Azimov2022internationalObservation Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors S. I. Azimov;
Journal International Journal of Health Systems and Medical Sciences
Year 2022
DOI
422
URL
https://inter-publishing.com/index.php/IJHSMS/article/view/422
Keywords
pulmonary tuberculosis surgical treatment urological pathology anti-tuberculosis chemotherapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.